Plaio, a Reykjavik, Iceland-based supplier of an AI-assisted determination assist platform for the pharmaceutical trade, raised €4.3M in funding.
The spherical was led by Iðunn, with participation from current traders Frumtak Ventures and Dr. Agon.
Earlier investments included Icelandic healthcare and pharma traders corresponding to European pharmaceutical corporations Coripharma and EpiEndo Prescription drugs, and worker psychological well being and wellbeing answer Kara Join.
The corporate intends to make use of the funds to implement strategic enhancements to the platform’s “AI Coplanner” providing, in addition to strengthen and develop each new and current partnerships to consolidate its place in AI pharma planning options.
Based by Johann Gudbjargarson Hlynur Stefansson and Eyjolfur Ingi Asgeirsson, Plaio is a software program firm behind the AI-driven platform empowering pharmaceutical provide chain planning combining trade experience with AI expertise to optimize complicated planning processes for the pharmaceutical trade.
Plaio’s consumer portfolio has grown by 200% within the final 12 months, and consists of, amongst others, Covis Pharma, built-in biopharmaceutical knowledgeable, Alvotech, and worldwide pharmaceutical firm Camarus.
FinSMEs
14/08/2024
